← back to search

Medha Munshi

Harvard University · US
Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Diabetes Treatment and Management, Diabetes Management and Education, and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
h-index
36
citations
6,308
works
191
NIH funding
primary concept
Medicine
email

Recent publications

Impact of Simplification Strategies on Postmeal Glucose Excursions in Older Adults with Type 1 Diabetes and Hypoglycemia.
2026cited by 0position: contributordoi
Challenges and Opportunities for Improving Care for Type 1 Diabetes in Older Adulthood.
2026cited by 0position: contributordoi
Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies
The Lancet Diabetes & Endocrinology 2025cited by 24position: firstdoi
Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial.
2025cited by 14position: contributordoi
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
The Lancet Diabetes & Endocrinology 2025cited by 9position: middledoi
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
Journal of Diabetes Science and Technology 2025cited by 4position: middledoi
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.
2025cited by 2position: contributordoi
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
Diabetes Technology & Therapeutics 2025cited by 1position: middledoi
Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study.
2025cited by 1position: contributordoi
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.
2025cited by 1position: contributordoi
Comparative safety and cardiovascular effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in nursing homes
Diabetes Obesity and Metabolism 2024cited by 11position: middledoi
Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes.
2024cited by 9position: contributordoi
Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials.
2024cited by 1position: contributordoi
When Type 1 Diabetes Meets Dementia: Practical Strategies to Help Patients and Their Loved Ones.
2024cited by 0position: contributordoi
The Growing Role of Technology in the Care of Older Adults With Diabetes
Diabetes Care 2023cited by 63position: lastdoi
The Growing Role of Technology in the Care of Older Adults With Diabetes.
2023cited by 50position: contributordoi
Continuous Glucose Monitoring Use in Older Adults for Optimal Diabetes Management.
2023cited by 34position: contributordoi
Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics.
2022cited by 35position: contributordoi
Can Smart Pens Help Improve Diabetes Management?
2022cited by 25position: contributordoi
Closed-Loop Insulin Therapy in Older Adults with Type 1 Diabetes: Real-World Data.
2022cited by 23position: contributordoi
Impact of Diabetes Duration on Functional and Clinical Status in Older Adults With Type 1 Diabetes.
2022cited by 16position: contributordoi
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience
Diabetes Care 2022cited by 10position: middledoi
Use of Telecommunication and Diabetes-Related Technologies in Older Adults With Type 1 Diabetes During a Time of Sudden Isolation: Mixed Methods Study.
2022cited by 8position: contributordoi
Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults.
2021cited by 86position: contributordoi
Comparative safety of dipeptidyl peptidase-4 inhibitors and sulfonylureas among frail older adults.
2021cited by 13position: contributordoi
Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
2021cited by 12position: contributordoi
Changes in mood and health-related quality of life in Look AHEAD 6 years after termination of the lifestyle intervention.
2021cited by 9position: contributordoi
A Successful Diabetes Management Model of Care in Long-Term Care Facilities.
2021cited by 6position: contributordoi
Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control.
2021cited by 3position: contributordoi
Erratum. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes. Diabetes Care 2020;43:2349-2354.
2021cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 16 papers (2020–2026)Elena Toschi · Harvard University12 papers (2020–2026) · 10 papers (2020–2026)Elbert S. Huang · General Department of Preventive Medicine8 papers (2012–2026)Richard E. Pratley · AdventHealth Translational Research Institute7 papers (2012–2025)Alan J. Sinclair · Juvenile Diabetes Research Foundation5 papers (2018–2025)Naushira Pandya · Nova Southeastern University5 papers (2013–2025)Marc D. Breton · University of Virginia4 papers (2025–2025)Carol J. Levy · Charlottesville Medical Research4 papers (2025–2025)Hermes Flórez · University of Miami4 papers (2012–2018)Gregory P. Forlenza · Children's Hospital Colorado4 papers (2025–2025)Michael C. Riddell · York University4 papers (2025–2025)Linda B. Haas · University of Oklahoma Health Sciences Center3 papers (2012–2016) · 3 papers (2012–2016)Kasia J. Lipska · Yale University3 papers (2023–2025)Graydon S. Meneilly · University of British Columbia3 papers (2020–2025)Tali Cukierman‐Yaffe · Tel Aviv University3 papers (2020–2025)Paul R. Conlin · Harvard University3 papers (2020–2023)Melissa S. Putman · Harvard University2 papers (2025–2025)David M. Maahs · University of Adelaide2 papers (2025–2025)